Table 1.
mRNA | Alternative 3′UTR | miRNAs | Cells/Disease | Reference |
---|---|---|---|---|
Igf1 | APA | LF:miR-29,miR-365 | Osteoblastic differentiation | [103] |
CCND1 | APA | LF:over80miRNAs | Mantle cell lymphoma | [104] |
Ki-67 | APA | LF:miR-133-3p,miR-140-3p | Breast cancer | [105] |
FNDC3B | APA | LF:23miRNAs | Nasopharyngeal carcinoma | [106] |
Tau | APA | LF:miR-34a | Neuroblastoma cell lines | [107] |
PolH | APA | LF:miR-619 | Lung or bladder cancer | [108] |
ABCB1 | APA | LF:miR-508-5p,miR-145 | Leukemia cells | [109] |
ABCC2 | APA | LF:miR-379 | Hepatoma cell line | [110] |
COX-2 | APA | n.s. | Colon tumors | [111] |
Hsp70.3 | APA | LF:miR-378 | Cardiac ischemic | [112] |
AAMDC | APA | LF:miR-2428/664a | Adipogenesis | [113] |
Many | APA * | n.s | Mammalian brain | [114] |
CYP20A1_Alu-LT | Exonized Alus | Over 140 miRNAs | Primary neurons | [115] |
NR2C1,GTSE1,FHL2,RAD1,FKBP9,CAD, SMA4 | Exonized Alus | miR-15a-3p | HeLa cells | [116] |
ADD1andUBE2I | Exonized Alus | miR-302d-3p | HeLa cells | [116] |
387genes | Retained intron | n.s. | n.s. | [117] |
CerS1 | Retained intron | miRNA-574-5p | HNSCC | [118] |
BCL11A | Alternative splicing | ExtraLF:miR-486-3p | Erythroid cells | [119] |
BCL2 | Alternative splicing | LF:miR-204 | HCT116 human colon cancercells | [120] |
ADAM12 | Alternative splicing | LF:miR-29andmiR-200 | Breast cáncer cells | [121] |
SEMA6Ba | Alternative splicing | miR-218,miR-19 ** | MCF-7cell line | [122] |
CD34 | Alternative splicing | LF:miR-193-5p,miR-125,miR-129-5p,miR-351-5p | Atherosclerosis | [123] |
APA: alternative polyadenylation; HNSCC: head/neck squamous carcinoma; LF: long form; n.s.: non-stated; * Very distal polyadenylation sites used, likely encoded by downstream lincRNAs; ** internal sites lost by alternative splicing.